Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced the election of Mark S. Davis to its Board of Directors, effective immediately, expanding the Board ...
Join us for panel discussions and spotlight presentations with more than 20 experts at the launch of the Center for China Analysis’s flagship report, China 2025: What to Watch. Join us in conversation ...